Elkfork Partners’s Novo Nordisk NVO Stock Holding History

Elkfork Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-28,784	Closed	-$678K	–	1051
2018 Q3	$678K	Hold	28,784	–	–	0.02%	499
2018 Q2	$664K	Hold	28,784	–	–	0.02%	449
2018 Q1	$709K	Hold	28,784	–	–	0.02%	430
2017 Q4	$773K	Hold	28,784	–	–	0.02%	419
2017 Q3	$693K	Hold	28,784	–	–	0.02%	408
2017 Q2	$617K	Hold	28,784	–	–	0.02%	441
2017 Q1	$493K	Hold	28,784	–	–	0.02%	459
2016 Q4	$516K	Buy	+28,784	New	+$522K	0.02%	405

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Elkfork Partners's NVO Position: Q4 2018 in Review

Elkfork Partners sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 28,784 shares — an estimated $678K sold.

Elkfork Partners first reported a position in NVO in Q4 2016 and held it in 8 quarters. The position peaked at $773K in Q4 2017. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

Elkfork Partners reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
Elkfork Partners sold 28,784 Novo Nordisk shares in Q4 2018, an estimated $678K.
Elkfork Partners first reported a position in Novo Nordisk in Q4 2016 and held it in 8 quarters.
Elkfork Partners's Novo Nordisk position peaked at $773K in Q4 2017.
550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Elkfork Partners's 13F filing for Q4 2018, filed 13 Feb 2019.